Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Prophylactic rhTPO for Chemotherapy-Induced Thrombocytopenia During EAP Mobilization
NCT07848672Phase 3Not yet recruiting
- Sponsor
- The Affiliated People’s Hospital of Ningbo University
- Start
- Jan 2027
- Primary completion
- Dec 2029
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia (CIT), sponsored by The Affiliated People’s Hospital of Ningbo University. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NCT07848672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848672.